Preventing HIV Just Got A Lot Cheaper. What Took So Long?
After nearly a decade of sky-high prices, generics have sent the price of the HIV prevention drug PrEP plummeting. What kept it so expensive for so long, and will the price drop help us finally eradicate HIV?
Robin Feldman, Professor of Law, UC Hastings; Director of the Center for Innovation
Tahir Amin, Co-Executive Director, I-MAK
Oni Blackstock, MD, Primary care and HIV physician
Tim Horn, Director of Health Care Access, National Alliance of State and Territorial AIDS Directors
Craig Garthwaite, Director of Health Care, Kellogg School of Management, Northwestern Univ.
Dig deeper into the research and tradeoffs of prescription drug pricing on our website: https://tradeoffs.org/2021/04/22/preventing-hiv-just-got-a-lot-cheaper-what-took-so-long/
Sign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff: bit.ly/tradeoffsnewsletter
Support this type of journalism today, with a gift: https://tradeoffs.org/donate
Follow us on Twitter: https://twitter.com/tradeoffspod
See acast.com/privacy for privacy and opt-out information.